Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.39 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4468251 | 0.80 | CASP3 (0.60) | ALDH1A1CA12CA9CASP3DRD3 | |
| SCHEMBL8950475 | 0.80 | CASP3 (0.60) | ALDH1A1CA12CA9CASP3DRD3 | |
| SCHEMBL4476083 | 0.80 | CASP3 (0.60) | ALDH1A1CA12CA9CASP3DRD3 | |
| SCHEMBL19595059 | 0.78 | CASP3 (0.47) | ALDH1A1CA12CA9CASP3NPC1 | |
| SCHEMBL16654973 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CA12CA9CASP3HPGD | |
| SCHEMBL16654972 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CA12CA9CASP3HPGD | |
| SCHEMBL23318802 | 0.76 | NPSR1 (0.48) | ALDH1A1CA12CA9CASP3 | |
| SCHEMBL28565124 | 0.76 | NPSR1 (0.48) | ALDH1A1CA12CA9CASP3 | |
| SCHEMBL10176436 | 0.75 | ALDH1A1 (0.42) | ALDH1A1CA12CA9CASP3 | |
| SCHEMBL9761279 | 0.75 | CASP3 (0.51) | ALDH1A1CA12CA9CASP3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0457250-B1 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL MYERS SQUIBB CO (US) | 1999-07-14 | — | — | EP | claimed |
| EP-0457250-A2 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL-MYERS SQUIBB COMPANY (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0457250-B1 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL MYERS SQUIBB CO (US) | 1999-07-14 | — | — | EP | disclosed |
| US-5349066-A | Antibodies | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| US-5137877-A | N-substituted hydrazine bifuctional derivative; cytotoxic reagent | BRISTOL-MYERS SQUIBB (US) | 1992-08-11 | — | — | US | disclosed |
| EP-0457250-A2 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL-MYERS SQUIBB COMPANY (US) | 1991-11-21 | — | — | EP | disclosed |